Search Within

Shanu Modi

  1. "Health Outcomes Research Group"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (6)
Groups
  1. Breast Medicine Service (22)
  2. Department of Medicine (22)
  3. Epidemiology and Biostatistics (22)
  4. Health Outcomes Research Group (22)
  5. Population Sciences Research Program (22)
  6. Solid Tumor Oncology Division (22)

More Groups

People
  1. Shari Goldfarb (22)
  2. Clifford Hudis (19)
  3. Diana Lake (19)
  4. Chau Dang (15)
  5. Maura Dickler (15)
  6. Monica Fornier (15)

More People

Years
  1. 2019 (3)
  2. 2018 (1)
  3. 2017 (3)
  4. 2016 (2)
  5. 2015 (3)
  6. 2014 (4)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer Research (6)
  3. Annals of Oncology (2)
  4. Clinical Breast Cancer (2)
  5. JAMA Dermatology (2)
  6. JAMA Network Open (1)
Publishers
  1. American Society of Clinical Oncology (9)
  2. American Association for Cancer Research (6)
  3. American Medical Association (3)
  4. Elsevier Inc. (2)
  5. Oxford University Press (2)

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients
    Meeting Abstract

    Chan, D.; Freites Martinez, A. D.; Goldfarb, S. B.; Modi, S.; Gajria, D.; Lacouture, M. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia
    Journal Article

    Freites-Martinez, A.; Chan, D.; Sibaud, V.; Shapiro, J.; Fabbrocini, G.; Tosti, A.; Cho, J.; Goldfarb, S.; Modi, S.; Gajria, D.; more...
    JAMA Dermatology (2019)

    Fulltext@MSK | Save
  • Endocrine therapy-induced alopecia in patients with breast cancer
    Journal Article

    Freites-Martinez, A.; Shapiro, J.; Chan, D.; Fornier, M.; Modi, S.; Gajria, D.; Dusza, S.; Goldfarb, S.; Lacouture, M. E.
    JAMA Dermatology (2018)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine (G), trastuzumab (H), and pertuzumab (P) for HER2-positive metastatic breast cancer (MBC) after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P. A.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S. B.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-Positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Dickler, M. N.; Fornier, M. N.; Goldfarb, S.; more...
    Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy
    Meeting Abstract

    Iyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • Phase I study of PI3Kα inhibitor BYL719 + aromatase inhibitor (AI) in patients (pts) with hormone receptor-positive (HR+) metastatic breast cancer (MBC)
    Meeting Abstract

    Shah, P. D.; Moynahan, M. E.; Modi, S.; Hamilton, N.; Caravella, B. A.; Zamora, S.; Dang, C.; Gilewski, T.; Traina, T.; Comen, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save